Aug 2026· Theranostics· Vol 16, pp. 8561 - 8579· 0 citations· 63 references
Medicine
TL;DR
The findings support a framework in which intact zinc availability, including ZnT3-associated zinc physiology, contributes to adult hippocampal neurogenic responses following FUS-mediated BBB modulation, and provides a mechanistic framework for the development of ultrasound-guided therapeutic strategies aimed at promoting repair-associated plasticity in neurological disorders.
Abstract
Rationale Transcranial focused ultrasound (FUS)-mediated blood-brain barrier (BBB) modulation is a promising non-invasive therapeutic strategy for targeted brain drug delivery. However, its direct regenerative potential to actively remodel the brain microenvironment and promote adult hippocampal neurogenesis remains largely unexplored owing to elusive molecular mediators. Here, we investigated whether zinc-dependent signaling contributes to adult hippocampal neurogenic responses following FUS-mediated BBB modulation. Methods We integrated pharmacological and genetic approaches in adult rodent models subjected to hippocampal-targeted low-intensity FUS with microbubbles. Neural progenitor proliferation and differentiation were quantified using BrdU and DCX labeling. To assess the contributions of extracellular/labile zinc availability and ZnT3-associated vesicular zinc physiology, intracerebroventricular zinc chelation with CaEDTA was performed in rats, and ZnT3˗/˗ mice were used. Molecular assays and exploratory bulk RNA sequencing were conducted to characterize candidate downstream molecular pathways. Results FUS-mediated BBB modulation significantly increased dentate gyrus progenitor proliferation, neuroblast abundance, and newborn neuron survival. These effects were markedly attenuated by acute zinc chelation and were not observed in ZnT3˗/˗ mice, indicating that intact zinc availability and ZnT3-associated zinc physiology are required for the full FUS-associated neurogenic response. FUS was associated with increased expression of brain-derived neurotrophic factor, Zrt-/Irt-like protein 3 (ZIP-3), and Piezo1 proteins, and zinc chelation attenuated these increases. ZIP-3 and Piezo1 signals overlapped with NeuN-positive cells, suggesting neuronal enrichment. In addition, exploratory bulk transcriptomic profiling of whole hippocampal tissue revealed candidate signatures associated with neurovascular and glial responses following FUS in ZnT3+/+ mice, whereas the corresponding transcriptomic responses appeared reduced or altered in ZnT3˗/˗ mice. Conclusions Our findings support a framework in which intact zinc availability, including ZnT3-associated zinc physiology, contributes to adult hippocampal neurogenic responses following FUS-mediated BBB modulation. This work provides a mechanistic framework for the development of ultrasound-guided therapeutic strategies aimed at promoting repair-associated plasticity in neurological disorders.
BBB microdisruption, particularly through FUS with microbubbles, represents a transformative platform for central nervous system gene therapy, and continued research is needed to standardize treatment protocols, characterize long-term safety, and facilitate broader clinical translation.
M. Rashad, Agastya Mittal, Srivardhan Chirasani et al.· Journal of Molecular Patholo...· 0 citations
A biphasic inflammatory response is identified, characterized by an initial NFκB-driven peak at 3–6 h, followed by an interferon-mediated phase at 48 h that attenuates by a week, providing insights into establishing therapeutic windows and enhancing neuroinflammatory modulation strategies.
Jane J. Song, Payton J. Martinez, Hannah A. Lopez et al.· Journal of Neuroinflammation· 0 citations
Microbubble-enhanced focused ultrasound (MB-FUS) enables noninvasive blood-brain barrier (BBB) opening to improve the delivery of drugs and other therapeutics to the brain, supporting more effective treatment of brain disorders. The benefits of this rapidly advancing and highly versatile technology have been demonstrat...
Sophie K. Elvig, Alexandra A. Seas, P. Anastasiadis et al.· bioRxiv· 0 citations
The blood-brain barrier (BBB) is a major obstacle to treating glioblastoma (GBM) by restricting the entry of most therapeutic molecules into the brain. Interspecies differences in BBB structure and function complicate the clinical translation of animal models, highlighting the need for human-relevant in vitro BBB platf...
Rationale The blood–brain barrier (BBB) remains a major obstacle to the delivery of therapeutics for central nervous system (CNS) diseases. Although several BBB-penetrating or BBB-bypassing strategies have been investigated, there remains a need for sustained, controllable delivery routes that can support prolonged CNS...
Ji-Hee Kang, O. H. Lee, Min Suk Shim et al.· Theranostics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.